Qube Research & Technologies Ltd
Position in PRTA — Prothena Corp Public Ltd Co
CIK 1729829
LONDON, X0
Position in PRTA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,745,544
+$1,771,603 QoQ
Shares Held
791,169
+28.7% QoQ
Ownership
1.54%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#17
of 187 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,443,068,185 across 169 Biotechnology names. PRTA ranks #56 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in PRTA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,745,544 | 791,169 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,973,941 | 614,603 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,893,429 | 407,689 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,481,431 | 254,245 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,518,005 | 414,828 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $222,843 | 13,320 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $4,841,197 | 195,446 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,401,803 | 203,682 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,084,507 | 84,653 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,826,587 | 41,397 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $399,295 | 8,238 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $433,800 | 7,200 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $376,787 | 13,878 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $218,286 | 5,969 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $979,750 | 19,833 | Shares | Sole | 2022-02-10 | |
| 2020-09-30 | $142,317 | 14,246 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $203,457 | 19,451 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||